-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Taro Pharmaceutical Industries Ltd quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2012 to Q1 2023.
- Taro Pharmaceutical Industries Ltd Deferred Tax Assets, Gross for the quarter ending March 31, 2023 was $131M, a 14.8% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)